Связь уровня эстрадиола с сердечно-сосудистыми осложнениями у мужчин по данным систематического обзора
- Авторы: Орлова Я.А.1, Сорокин Е.Д.1, Павлова З.Ш.1, Плисюк А.Г.1, Камалов А.А.1
-
Учреждения:
- Московский государственный университет имени М.В. Ломоносова
- Выпуск: Том 79, № 3 (2024)
- Страницы: 205-215
- Раздел: АКТУАЛЬНЫЕ ВОПРОСЫ КАРДИОЛОГИИ И СЕРДЕЧНО-СОСУДИСТОЙ ХИРУРГИИ
- Дата публикации: 15.08.2024
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/17954
- DOI: https://doi.org/10.15690/vramn17954
- ID: 17954
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Сердечно-сосудистые заболевания (ССЗ) определяют более высокую смертность мужчин среднего и пожилого возраста по сравнению с женщинами. Действие половых гормонов на сердечно-сосудистую систему является наиболее вероятным механизмом этих различий. При этом роль эстрадиола в патофизиологии ССЗ до сих пор не определена. Проведен экстенсивный поиск публикаций в системе MedLine (1961 — июль 2023 г.) с использованием ключевых слов «эстрадиол», «сердечно-сосудистые заболевания», «мужчины», «люди». Методы синтеза не использовались. 24 публикации соответствовало критериям поиска. В 10 исследованиях не было обнаружено связи между уровнями половых гормонов и конечными событиями. В 7 исследованиях найдена ассоциация тестостерона с конечными точками, но не было получено значимых результатов по эстрадиолу. Было выявлено 7 исследований, в которых найдена ассоциация эстрадиола с конечными точками. На различия в опубликованных результатах значимо влияли возраст пациентов, метод определения эстрадиола, дизайн исследования, его длительность и конечные точки. Более 40% опубликованных работ, в которых изучалась ассоциация уровня эстрадиола со смертностью, выявило наличие такой связи. Однако гетерогенность опубликованных данных не позволяет сделать окончательные выводы о влиянии уровня эстрадиола на сердечно-сосудистые риски в мужской популяции в целом. Проведенный нами анализ показывает, что с наибольшей вероятностью уровень эстрадиола может быть ассоциирован с риском развития болезней системы кровообращения у белых мужчин молодого и среднего возраста.
Ключевые слова
Полный текст
Об авторах
Яна Артуровна Орлова
Московский государственный университет имени М.В. Ломоносова
Email: YAOrlova@mc.msu.ru
ORCID iD: 0000-0002-8160-5612
SPIN-код: 3153-8373
д.м.н., профессор
Россия, МоскваЕгор Дмитриевич Сорокин
Московский государственный университет имени М.В. Ломоносова
Автор, ответственный за переписку.
Email: srknegor@gmail.com
ORCID iD: 0009-0002-5730-4286
Россия, Москва
Зухра Шариповна Павлова
Московский государственный университет имени М.В. Ломоносова
Email: zukhra73@gmail.com
ORCID iD: 0000-0001-7954-0437
SPIN-код: 9329-7628
д.м.н.
Россия, МоскваАлина Геннадьевна Плисюк
Московский государственный университет имени М.В. Ломоносова
Email: apl.cardio@yandex.ru
ORCID iD: 0000-0003-2015-4712
SPIN-код: 3541-2077
к.м.н., доцент
Россия, МоскваАрмаис Альбертович Камалов
Московский государственный университет имени М.В. Ломоносова
Email: AAKamalov@mc.msu.ru
ORCID iD: 0000-0003-4251-7545
SPIN-код: 6609-5468
д.м.н., профессор, академик РАН
Россия, МоскваСписок литературы
- Федеральная служба государственной статистики. Женщины и мужчины России 2022: стат. сборник. — М., 2022. — 208 с. [Federalnaya sluzhba gosudarstvennoj statistiki. ZHenshchiny i muzhchiny Rossii 2022: Statisticheskij sbornik. Moscow; 2022. 208 p. (In Russ.)]
- Tsilidis KK, Rohrmann S, Mcglynn KA, et al. Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology. 2013;1(6):919–928. doi: https://doi.org/10.1111/J.2047-2927.2013.00129.x
- Ellis JA, Infantino T, Harrap SB. Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta. J Hypertens. 2004;22(6):1127–1131. doi: https://doi.org/10.1097/00004872-200406000-00013
- Stachenfeld NS, Keefe DL. Estrogen effects on osmotic regulation of AVP and fluid balance. Am J Physiol Endocrinol Metab. 2002;283(4):Е711–721. doi: https://doi.org/10.1152/ajpendo.00192.2002
- The Coronary Drug Project: Findings Leading to Discontinuation of the 2,5-mg/day Estrogen Group. JAMA. 1973;226(6):652–657. doi: https://doi.org/10.1001/JAMA.1973.03230060030009
- Blackard CE, Doe RP, Mellinger GT, Byar DP. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer. 1970;26(2):249–256. doi: https://doi.org/10.1002/1097-0142(197008)26:2<249::aid-cncr2820260202>3.0.co;2-7
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: https://doi.org/10.1136/BMJ.n71
- Haffner SM, Moss SE, Klein BE, et al. Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1996;19(10):1045–1050. doi: https://doi.org/10.2337/diacare.19.10.1045
- Lerchbaum E, Pilz S, Grammer TB, et al. High estradiol levels are associated with increased mortality in older men referred to coronary angiography. Exp Clin Endocrinol Diabetes. 2011;119(8):490–496. doi: https://doi.org/10.1055/S-0031-1284370
- Raparelli V, Nocella C, Proietti M, et al. Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project. J Endocrinol Invest. 2022;45(7):1367–1377. doi: https://doi.org/10.1007/S40618-022-01771-0
- Cai J, Li J, Chen S, et al. Early post-haemorrhagic stroke testosterone and oestradiol levels and long-term risk of death. Brain Inj. 2017;31(3):401–405. doi: https://doi.org/10.1080/02699052.2016.1265668
- Van Koeverden ID, De Bakker M, Haitjema S, et al. Testosterone to oestradiol ratio reflects systemic and plaque inflammation and predicts future cardiovascular events in men with severe atherosclerosis. Cardiovasc Res. 2019;115(2):453–462. doi: https://doi.org/10.1093/cvr/cvy188
- Jankowska EA, Rozentryt P, Ponikowska B, et al. Circulating Estradiol and Mortality in Men with Systolic Chronic Heart Failure. JAMA. 2009;301(18):1892–1901. doi: https://doi.org/10.1001/jama.2009.639
- Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992;2(5):675–682. doi: https://doi.org/10.1016/1047-2797(92)90012-f
- Haring R, Travison TG, Bhasin S, et al. Relation between Sex Hormone Concentrations, Peripheral Arterial Disease, and Change in Ankle-Brachial Index: Findings from the Framingham Heart Study. J Clin Endocrinol Metab. 2011;96(12):3724–3732. doi: https://doi.org/10.1210/jc.2011-1068
- Holmegard HN, Nordestgaard BG, Schnohr P, et al. Endogenous sex hormones and risk of venous thromboembolism in women and men. J Thromb Haemost. 2014;12(3):297–305. doi: https://doi.org/10.1111/jth.12484
- Magnani JW, Moser CB, Murabito JM, et al. Association of sex hormones, aging, and atrial fibrillation in men the framingham heart study. Circ Arrhythm Electrophysiol. 2014;7(2):307–312. doi: https://doi.org/10.1161/CIRCEP.113.001322
- Chasland LC, Knuiman MW, Divitini ML, et al. Greater physical activity and higher androgen concentrations are independently associated with lower cardiometabolic risk in men. Clin Endocrinol (Oxf). 2017;87(5):466–474. doi: https://doi.org/10.1111/cen.13407
- Chan YX, Knuiman MW, Hung J, et al. Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17–97 years. Clin Endocrinol (Oxf). 2016;85(4):575–582. doi: https://doi.org/10.1111/cen.13089
- Chasland LC, Knuiman MW, Divitini ML, et al. Higher circulating androgens and higher physical activity levels are associated with less central adiposity and lower risk of cardiovascular death in older men. Clin Endocrinol (Oxf). 2019;90(2):375–383. doi: https://doi.org/10.1111/cen.13905
- Yeap BB, Alfonso H, Paul Chubb SA, et al. In Older Men an Optimal Plasma Testosterone Is Associated with Reduced All-Cause Mortality and Higher Dihydrotestosterone with Reduced Ischemic Heart Disease Mortality, While Estradiol Levels Do Not Predict Mortality. J Clin Endocrinol Metab. 2014;99(1):E9–E18. doi: https://doi.org/10.1210/jc.2013-3272
- Yeap BB, Alfonso H, Chubb SAP, et al. In Older Men, Higher Plasma Testosterone or Dihydrotestosterone Is an Independent Predictor for Reduced Incidence of Stroke but Not Myocardial Infarction. J Clin Endocrinol Metab. 2014;99(12):4565–4573. doi: https://doi.org/10.1210/jc.2014-2664
- Heller RF, Miller NE, Wheeler MJ, et al. Coronary heart disease in “low risk” men. Atherosclerosis. 1983;49(2):187–193. doi: https://doi.org/10.1016/0021-9150(83)90196-x
- Cauley JA, Gutai JP, Kuller LH, et al. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol. 1987;60(10):771–777. doi: https://doi.org/10.1016/0002-9149(87)91021-6
- Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation. 1988;78(3):539–545. doi: https://doi.org/10.1161/01.cir.78.3.539
- Eldrup E, Winkel P, Lindholm J, et al. Coronary risk factors, development of mycocardial infarction, and plasma oestrogens: a prospective casecontrol study in men. J Intern Med. 1989;225(6):367–372. doi: https://doi.org/10.1111/j.1365-2796.1989.tb00098.x
- Contoreggi CS, Blackman MR, Andres R, et al. Plasma Levels of Estradiol, Testosterone, and DHEAS Do Not Predict Risk of Coronary Artery Disease in Men. J Androl. 1990;11(5):460–470. doi: https://doi.org/10.1002/j.1939-4640.1990.tb00178.x
- Yarnell JWG, Beswick AD, Sweetnam PM, et al. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arterioscler Thromb. 1993;13(4):517–520. doi: https://doi.org/10.1161/01.atv.13.4.517
- Mikulec KH, Holloway L, Krasnow RE, et al. Relationship of Endogenous Sex Hormones to Coronary Heart Disease: A Twin Study. J Clin Endocrinol Metab. 2004;89(3):1240–1245. doi: https://doi.org/10.1210/jc.2003-031333
- Nilsson SE, Fransson E, Brismar K. Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: An 8-Year prospective study. Gend Med. 2009;6(3):433–443. doi: https://doi.org/10.1016/j.genm.2009.09.011
- Glisic M, Mujaj B, Rueda-Ochoa OL, et al. Associations of Endogenous Estradiol and Testosterone Levels with Plaque Composition and Risk of Stroke in Subjects with Carotid Atherosclerosis. Circ Res. 2018;122(1):97–105. doi: https://doi.org/10.1161/CIRCRESAHA.117.311681
- Laughlin GA, Barrett-Connor E, Bergstrom J. Low Serum Testosterone and Mortality in Older Men. J Clin Endocrinol Metab. 2008;93(1):68–75. doi: https://doi.org/10.1210/jc.2007-1792
- Vikan T, Schirmer H, Njølstad I, et al. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol. 2009;161(3):435–442. doi: https://doi.org/10.1530/eje-09-0284
- Akishita M, Hashimoto M, Ohike Y, et al. Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. Atherosclerosis. 2010;210(1):232–236. doi: https://doi.org/10.1016/j.atherosclerosis.2009.10.037
- Haring R, Teng Z, Xanthakis V, et al. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf). 2013;78(4):629–634. doi: https://doi.org/10.1111/cen.12013
- Soisson V, Brailly-Tabard S, Helmer C, et al. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas. 2013;75(3):282–288. doi: https://doi.org/10.1016/j.maturitas.2013.04.012
- Holmegard HN, Nordestgaard BG, Jensen GB, et al. Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses. J Clin Endocrinol Metab. 2016;101(1):69–78. doi: https://doi.org/10.1210/jc.2015-2687
- Ärnlöv J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006;145(3):176–184. doi: https://doi.org/10.7326/0003-4819-145-3-200608010-00005
- Abbott RD, Launer LJ, Rodriguez BL, et al. Serum estradiol and risk of stroke in elderly men. Neurology. 2007;68(8):563–568. doi: https://doi.org/10.1212/01.wnl.0000254473.88647.ca
- Szulc P, Claustrat B, Delmas PD. Serum concentrations of 17β-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men – the MINOS study. Clin Endocrinol (Oxf). 2009;71(4):594–602. doi: https://doi.org/10.1111/j.1365-2265.2009.03530.x
- Tivesten Å, Vandenput L, Labrie F, et al. Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men. J Clin Endocrinol Metab. 2009;94(7):2482–2488. doi: https://doi.org/10.1210/jc.2008-2650
- Menke A, Guallar E, Rohrmann S, et al. Sex Steroid Hormone Concentrations and Risk of Death in US Men. Am J Epidemiol. 2010;171(5):583–592. doi: https://doi.org/10.1093/aje/kwp415
- Holmboe SA, Vradi E, Jensen TK, et al. The Association of Reproductive Hormone Levels and All-Cause, Cancer, and Cardiovascular Disease Mortality in Men. J Clin Endocrinol Metab. 2015;100(12):4472–4480. doi: https://doi.org/10.1210/jc.2015-2460
- Appiah D, Luitel S, Nwabuo CC, et al. Low endogenous estradiol levels are associated with elevated risk of cardiovascular disease mortality in young and middle-aged men in the United States. Atherosclerosis. 2022;361:34–40. doi: https://doi.org/10.1016/j.atherosclerosis.2022.09.006
- Vandenplas G, De Bacquer D, Calders P, et al. Endogenous oestradiol and cardiovascular disease in healthy men: a systematic review and meta-analysis of prospective studies. Heart. 2012;98(20):1478–1482. doi: https://doi.org/10.1136/heartjnl-2011-301587
- Bräuner EV, Uldbjerg C, Lim YH, et al. Is male gynaecomastia associated with an increased risk of death? A nationwide register-based cohort study. BMJ Open. 2024;14(2):e076608. doi: https://doi.org/10.1136/bmjopen-2023-076608
- Uldbjerg CS, Lim YH, Bräuner EV, et al. Increased Morbidity in Males Diagnosed With Gynecomastia: A Nationwide Register-based Cohort Study. J Clin Endocrinol Metab. 2023;108(7):e380–e387. doi: https://doi.org/10.1210/clinem/dgad048
- Chadid S, Barber JR, Rohrmann S, et al. Age-Specific Serum Total and Free Estradiol Concentrations in Healthy Men in US Nationally Representative Samples. J Endocr Soc. 2019;3(10):1825. doi: https://doi.org/10.1210/js.2019-00178
- EEST — Overview: Estradiol, Serum. Available from: https://www.mayocliniclabs.com/test-catalog/overview/81816#Clinical-and-Interpretive (accessed: 21.01.2024).
- Fernandez CJ, Chacko EC, Pappachan JM. Male Obesity-related Secondary Hypogonadism — Pathophysiology, Clinical Implications and Management. Eur Endocrinol. 2019;15(2):83. doi: https://doi.org/10.17925/EE.2019.15.2.83
- Rohrmann S, Nelson WG, Rifai N, et al. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab. 2007;92(7):2519–2525. doi: https://doi.org/10.1210/jc.2007-0028
- Fiers T, Casetta B, Bernaert B, et al. Development of a highly sensitive method for the quantification of estrone and estradiol in serum by liquid chromatography tandem mass spectrometry without derivatization. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;893–894:57–62. doi: https://doi.org/10.1016/j.jchromb.2012.02.034
- Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol. 2010;121(3–5):481–490. doi: https://doi.org/10.1016/j.jsbmb.2010.02.017
- Cerda-Kipper AS, Montiel BE, Hosseini S. Radioimmunoassays and Enzyme-Linked Immunosorbent Assay. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. doi: https://doi.org/10.1016/B978-0-12-409547-2.14510-X
- Ohlsson C, Nilsson ME, Tivesten Å, et al. Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. J Clin Endocrinol Metab. 2013;98(6):E1097–1102. doi: https://doi.org/10.1210/jc.2012-3861
- Figtree GA, Ngo DTM, Bubb KJ. Testosterone to estradiol ratio and plaque inflammation: mechanistic insights and biomarker potential? Cardiovasc Res. 2019;115(2):255–257. doi: https://doi.org/10.1093/cvr/cvy260